AMAZING PRAGUE (PRAGUE-12)
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Apr 23, 2008
Trial Information
Current as of May 07, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • indication to a cardiac surgery (coronary bypass, valve repair, others or combination of those)
- • atrial fibrillation (paroxysmal, persistent or permanent) present or documented in last 6 month before the operation
- • signed informed consent
- Exclusion Criteria:
- • rejection of signing the informed consent with randomization
- • emergent surgery
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pilsen, , Czech Republic
Prague, , Czech Republic
Usti Nad Labem, , Czech Republic
Patients applied
Trial Officials
Zbynek Straka, Prof.,MUDr.,CSc.
Principal Investigator
Charles University, Prague
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials